Developing broad-spectrum vaccines and optimal vaccination strategies is crucial to
controlling the COVID-19 pandemic. Here, we generated a chimpanzee adenoviral vector …

Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable
vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated …

Messenger RNA (mRNA) vaccine technology has shown its power in preventing the
ongoing COVID-19 pandemic. Two mRNA vaccines targeting the full-length S protein of …

To contain the coronavirus disease 2019 (COVID-19) pandemic, a safe and effective
vaccine against the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is …

Oral delivery of an inexpensive COVID-19 (coronavirus disease 2019) vaccine could
dramatically improve immunization rates, especially in low-and middle-income countries …

The mRNA vaccines (RVs) can reduce the severity and mortality of severe acute respiratory
syndrome coronavirus (SARS-CoV-2). However, almost only the inactivated vaccines (IVs) …

To generate an inexpensive readily manufactured COVID-19 vaccine, we employed the LVS
Δ capB vector platform, previously used to generate potent candidate vaccines against …

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
highlights the importance of determining the breadth and durability of humoral immunity to …

Two-dose messenger RNA vaccines against the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are highly effective in preventing symptomatic COVID-19 …

Because of the relatively limited understanding of coronavirus disease 2019 (COVID-19)
pathogenesis, immunological analysis for vaccine development is needed. Mice and …